New Delhi: The corona epidemic continues to plague the entire country. Meanwhile, there is a huge shortage of oxygen, oxygen cylinders, Remdesivir and corona virus related devices. While the government has laid more emphasis on oxygen production in the last few days, oxygen has been supplied to various states by running oxygen express.
However, Foreign Secretary Harsh Vardhan Shringla has said on the situation of corona epidemic that we are working towards achieving more than 500 oxygen production plants from different parts of the world. We are working to acquire 4,000 oxygen concentrations, 10,000 oxygen cylinders from abroad, he further added.
On the other hand, the Foreign Secretary has informed that India generally produces 67,000 doses of Remdesivir daily, but at present we need two to three lakh doses. We have asked our producers to increase capacity, he added. Companies need raw materials. That is where we have the support of the US Government, which has assured to provide
Second Wave in India: Devastating Reminder of What Coronavirus can Do by Hannah Joy on April 26, 2021 at 4:10 PM
Tedros Adhanom Ghebreyesus, the chief of the World Health Organization (WHO), said that he is very concerned about the rising of coronavirus cases in India, as the second wave of Covid-19 has created havoc in the country. The situation in India is a devastating reminder of what the virus can do, Ghebreyesus said during a virtual briefing in Geneva.
The situation in the country seems to be slipping out of hands with each passing day, amid acute shortage of oxygen beds and key emergency drugs like Remdesivir.
IMA flags shortage of Remdesivir in private hospitals in Tiruppur
Updated:
Updated:
Share Article
AAA
The Tiruppur branch of Indian Medical Association (IMA) recently wrote to the Tamil Nadu Medical Services Corporation (TNMSC) flagging the shortage of anti-viral drug Remdesivir used in the treatment for COVID-19 in private hospitals.
In the letter written on Friday, IMA Tiruppur secretary M.P. Senthilkumar said that around 20 private hospitals were treating COVID-19 patients in the district and that these hospitals were allegedly unable to purchase Remdesivir from private pharmaceutical companies. Noting that the drug was important for patients suffering from severe COVID-19 cases to prevent further worsening of their condition, Dr. Senthilkumar requested the TNMSC to provide Remdesivir injections to the private hospitals in Tiruppur district at the earliest.
Remdesivir isn t a magic bullet : AIIMS chief on drug s use to treat Covid-19
Premium
(ANI)
Share Via
Read Full Story
As India reels under the massive surge of Covid-19 cases in the second wave of the pandemic, the All India Institute of Medical Sciences (AIIMS) Delhi director Dr Randeep Guleria highlighted some pertinent points of Covid management in the country.
In an interview, AIIMS chief spoke at length about the treatment of Covid-19 through drugs, steroids and CT scans.
TRENDING STORIESSee All
3 min read
Premium
2 min read
Premium
1 min read
Premium
1 min read
. 08:41 AM IST
Highlighting the usage of the anti-viral drug Remdesivir, Guleria informed, It s important to understand that Remdesivir isn t magic bullet and isn t a drug that decreases mortality. We may use it as we don t have an anti-viral drug. It s of no use if given early to asymptomatic individuals/ones with mild symptoms. Also of no use, if given late, according to news agency